vs
伯乐实验室(BIO)与Ryman Hospitality Properties, Inc.(RHP)财务数据对比。点击上方公司名可切换其他公司
Ryman Hospitality Properties, Inc.的季度营收约是伯乐实验室的1.1倍($737.8M vs $693.2M),伯乐实验室净利率更高(103.9% vs 10.1%,领先93.8%),Ryman Hospitality Properties, Inc.同比增速更快(13.9% vs 3.9%),伯乐实验室自由现金流更多($119.1M vs $58.5M),过去两年Ryman Hospitality Properties, Inc.的营收复合增速更高(18.2% vs 6.5%)
美国伯乐实验室是深耕生命科学研究与临床诊断领域的专业技术产品开发商及制造商,1952年由加州大学伯克利分校校友施瓦茨夫妇在伯克利创立,总部位于加州赫拉克勒斯,业务网络覆盖全球。
莱曼酒店地产是一家主营酒店、度假村、娱乐及媒体业务的企业,得名于旗下位于田纳西州纳什维尔的国家历史地标莱曼礼堂。公司历史可追溯至曾为俄克拉荷马出版公司子公司时期,1983年收购WSM公司后奠定现代业务基础,同时将知名演出IP大奥普里等核心资产纳入麾下。
BIO vs RHP — 直观对比
营收规模更大
RHP
是对方的1.1倍
$693.2M
营收增速更快
RHP
高出10.1%
3.9%
净利率更高
BIO
高出93.8%
10.1%
自由现金流更多
BIO
多$60.6M
$58.5M
两年增速更快
RHP
近两年复合增速
6.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $693.2M | $737.8M |
| 净利润 | $720.0M | $74.5M |
| 毛利率 | 49.8% | 41.4% |
| 营业利润率 | -17.2% | 19.4% |
| 净利率 | 103.9% | 10.1% |
| 营收同比 | 3.9% | 13.9% |
| 净利润同比 | 200.6% | 3.0% |
| 每股收益(稀释后) | $26.59 | $1.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
BIO
RHP
| Q4 25 | $693.2M | $737.8M | ||
| Q3 25 | $653.0M | $592.5M | ||
| Q2 25 | $651.6M | $659.5M | ||
| Q1 25 | $585.4M | $587.3M | ||
| Q4 24 | $667.5M | $647.6M | ||
| Q3 24 | $649.7M | $550.0M | ||
| Q2 24 | $638.5M | $613.3M | ||
| Q1 24 | $610.8M | $528.3M |
净利润
BIO
RHP
| Q4 25 | $720.0M | $74.5M | ||
| Q3 25 | $-341.9M | $34.9M | ||
| Q2 25 | $317.8M | $71.8M | ||
| Q1 25 | $64.0M | $63.0M | ||
| Q4 24 | $-715.8M | $72.3M | ||
| Q3 24 | $653.2M | $59.0M | ||
| Q2 24 | $-2.2B | $100.8M | ||
| Q1 24 | $383.9M | $42.8M |
毛利率
BIO
RHP
| Q4 25 | 49.8% | 41.4% | ||
| Q3 25 | 52.6% | 40.9% | ||
| Q2 25 | 53.0% | 49.7% | ||
| Q1 25 | 52.3% | 44.4% | ||
| Q4 24 | 51.2% | 40.4% | ||
| Q3 24 | 54.8% | 43.1% | ||
| Q2 24 | 55.6% | 48.4% | ||
| Q1 24 | 53.4% | 41.5% |
营业利润率
BIO
RHP
| Q4 25 | -17.2% | 19.4% | ||
| Q3 25 | 10.0% | 15.0% | ||
| Q2 25 | 11.8% | 21.1% | ||
| Q1 25 | 4.0% | 19.8% | ||
| Q4 24 | 8.7% | 18.6% | ||
| Q3 24 | 9.9% | 19.3% | ||
| Q2 24 | 15.9% | 27.4% | ||
| Q1 24 | 7.3% | 18.2% |
净利率
BIO
RHP
| Q4 25 | 103.9% | 10.1% | ||
| Q3 25 | -52.4% | 5.9% | ||
| Q2 25 | 48.8% | 10.9% | ||
| Q1 25 | 10.9% | 10.7% | ||
| Q4 24 | -107.2% | 11.2% | ||
| Q3 24 | 100.5% | 10.7% | ||
| Q2 24 | -339.2% | 16.4% | ||
| Q1 24 | 62.9% | 8.1% |
每股收益(稀释后)
BIO
RHP
| Q4 25 | $26.59 | $1.12 | ||
| Q3 25 | $-12.70 | $0.53 | ||
| Q2 25 | $11.67 | $1.12 | ||
| Q1 25 | $2.29 | $1.00 | ||
| Q4 24 | $-25.89 | $1.12 | ||
| Q3 24 | $23.34 | $0.94 | ||
| Q2 24 | $-76.26 | $1.65 | ||
| Q1 24 | $13.45 | $0.67 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $1.5B | $471.4M |
| 总债务越低越好 | $1.2B | — |
| 股东权益账面价值 | $7.5B | $750.2M |
| 总资产 | $10.6B | $6.2B |
| 负债/权益比越低杠杆越低 | 0.16× | — |
8季度趋势,按日历期对齐
现金及短期投资
BIO
RHP
| Q4 25 | $1.5B | $471.4M | ||
| Q3 25 | $1.4B | $483.3M | ||
| Q2 25 | $1.4B | $420.6M | ||
| Q1 25 | $1.7B | $413.9M | ||
| Q4 24 | $1.7B | $477.7M | ||
| Q3 24 | $1.6B | $534.9M | ||
| Q2 24 | $1.6B | $498.4M | ||
| Q1 24 | $1.6B | $465.3M |
总债务
BIO
RHP
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.2B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
BIO
RHP
| Q4 25 | $7.5B | $750.2M | ||
| Q3 25 | $6.7B | $758.5M | ||
| Q2 25 | $7.1B | $800.4M | ||
| Q1 25 | $6.7B | $531.5M | ||
| Q4 24 | $6.6B | $549.0M | ||
| Q3 24 | $7.5B | $551.9M | ||
| Q2 24 | $6.8B | $562.6M | ||
| Q1 24 | $9.1B | $529.9M |
总资产
BIO
RHP
| Q4 25 | $10.6B | $6.2B | ||
| Q3 25 | $9.7B | $6.2B | ||
| Q2 25 | $10.2B | $6.1B | ||
| Q1 25 | $9.5B | $5.2B | ||
| Q4 24 | $9.4B | $5.2B | ||
| Q3 24 | $10.6B | $5.2B | ||
| Q2 24 | $9.7B | $5.1B | ||
| Q1 24 | $12.6B | $5.1B |
负债/权益比
BIO
RHP
| Q4 25 | 0.16× | — | ||
| Q3 25 | 0.18× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.18× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $164.9M | $164.7M |
| 自由现金流经营现金流 - 资本支出 | $119.1M | $58.5M |
| 自由现金流率自由现金流/营收 | 17.2% | 7.9% |
| 资本支出强度资本支出/营收 | 6.6% | 14.4% |
| 现金转化率经营现金流/净利润 | 0.23× | 2.21× |
| 过去12个月自由现金流最近4个季度 | $374.6M | $232.4M |
8季度趋势,按日历期对齐
经营现金流
BIO
RHP
| Q4 25 | $164.9M | $164.7M | ||
| Q3 25 | $120.9M | $205.2M | ||
| Q2 25 | $116.5M | $122.5M | ||
| Q1 25 | $129.9M | $98.2M | ||
| Q4 24 | $124.2M | $166.6M | ||
| Q3 24 | $163.6M | $218.1M | ||
| Q2 24 | $97.6M | $184.3M | ||
| Q1 24 | $69.8M | $7.5M |
自由现金流
BIO
RHP
| Q4 25 | $119.1M | $58.5M | ||
| Q3 25 | $89.2M | $135.4M | ||
| Q2 25 | $70.8M | $53.0M | ||
| Q1 25 | $95.5M | $-14.5M | ||
| Q4 24 | $81.2M | $76.0M | ||
| Q3 24 | $123.4M | $85.7M | ||
| Q2 24 | $55.4M | $78.8M | ||
| Q1 24 | $29.6M | $-72.0M |
自由现金流率
BIO
RHP
| Q4 25 | 17.2% | 7.9% | ||
| Q3 25 | 13.7% | 22.9% | ||
| Q2 25 | 10.9% | 8.0% | ||
| Q1 25 | 16.3% | -2.5% | ||
| Q4 24 | 12.2% | 11.7% | ||
| Q3 24 | 19.0% | 15.6% | ||
| Q2 24 | 8.7% | 12.9% | ||
| Q1 24 | 4.8% | -13.6% |
资本支出强度
BIO
RHP
| Q4 25 | 6.6% | 14.4% | ||
| Q3 25 | 4.9% | 11.8% | ||
| Q2 25 | 7.0% | 10.5% | ||
| Q1 25 | 5.9% | 19.2% | ||
| Q4 24 | 6.4% | 14.0% | ||
| Q3 24 | 6.2% | 24.1% | ||
| Q2 24 | 6.6% | 17.2% | ||
| Q1 24 | 6.6% | 15.0% |
现金转化率
BIO
RHP
| Q4 25 | 0.23× | 2.21× | ||
| Q3 25 | — | 5.88× | ||
| Q2 25 | 0.37× | 1.71× | ||
| Q1 25 | 2.03× | 1.56× | ||
| Q4 24 | — | 2.30× | ||
| Q3 24 | 0.25× | 3.70× | ||
| Q2 24 | — | 1.83× | ||
| Q1 24 | 0.18× | 0.17× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BIO
| Clinical Diagnostics | $425.3M | 61% |
| Life Science | $267.9M | 39% |
RHP
| Hotel Other | $157.7M | 21% |
| Gaylord Opryland | $147.4M | 20% |
| Hotel Transient Rooms | $93.6M | 13% |
| Hotel Food And Beverage Outlets | $92.2M | 12% |
| Gaylord Palms | $88.2M | 12% |
| Jw Marriott Hill Country | $53.7M | 7% |
| Entertainment Admissions And Ticketing | $43.1M | 6% |
| Entertainment Food And Beverage | $38.1M | 5% |
| Entertainment Retail And Other | $28.3M | 4% |
| Ac Hotel | $2.4M | 0% |